Clinical Trial: Study on Onset Time and Safety of Single-Concentration Accelerated Regimen Subcutaneous Immunotherapy (SCIT) in Chinese Children and Adolescents with Allergic Rhinitis with or without Asthma Who Discontinued Sublingual Immunotherapy (SLIT) (China)

China, Aug. 31 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Study on Onset Time and Safety of Single-Concentration Accelerated Regimen Subcutaneous Immunotherapy (SCIT) in Chinese Children and Adolescents with Allergic Rhinitis with or without Asthma Who Discontinued Sublingual Immunotherapy (SLIT)'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600131057

Registration Time: 2026/08/27

Type: Interventional study

Primary Sponsor: Hunan Provincial People's Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=333962

Published by HT Digital Content Services with permission from Health Daily Digest....